Table 2.
Cancer risk ratio in type 2 diabetic patients with no aspirin nor dipyridamole user, dipyridamole user, and aspirin user.
| No. of cases | No aspirin nor dipyridamole user | Dipyridamole user | Aspirin user | ||
|---|---|---|---|---|---|
| N (%) | N (%) | N (%) | P value | ||
| Any type of cancer | 536 | 135 (12.0) | 150 (11.2) | 251 (97) | .0807 |
| All-cause mortality | 496 | 92 (7.8) | 135 (9.5) | 269 (9.9) | .1134 |
| Liver | 135 | 46 (4.0) | 34 (2.4) | 55 (2.0) | .0024 |
| Colon | 43 | 10 (0.9) | 13 (0.9) | 20 (0.7) | .8253 |
| Lung | 67 | 17 (1.5) | 16 (1.1) | 34 (1.3) | .7834 |
| Breast | 35 | 11 (0.9) | 8 (0.6) | 16 (0.6) | .4144 |
| Prostate | 26 | 6 (0.5) | 7 (0.5) | 13 (0.5) | .9925 |
| Rectum | 36 | 9 (0.8) | 12 (0.8) | 15 (0.6) | .5197 |
| Stomach | 26 | 8 (0.7) | 7 (0.5) | 11 (0.4) | .5305 |
| Bladder | 18 | 3 (0.3) | 10 (0.7) | 5 (0.2) | .0207 |
| Cervix | 16 | 3 (0.3) | 4 (0.3) | 9 (0.3) | .9088 |
| Kidney | 24 | 4 (0.3) | 11 (0.8) | 9 (0.3) | .1069 |
| Lymphoma | 7 | 4 (0.3) | 2 (0.1) | 1 (0.0) | .0567 |
| Esophagus | 10 | 5 (0.4) | 2 (0.1) | 3 (0.1) | .1030 |
| Pancreas | 13 | 4 (0.3) | 2 (0.1) | 7 (0.3) | .5781 |
| Bile duct | 6 | 1 (0.1) | 0 (0.0) | 5 (0.2) | .2316 |
| Larynx | 3 | 1 (0.1) | 0 (0.0) | 2 (0.1) | .5715 |
| Ovary | 3 | 0 (0.0) | 1 (0.1) | 2 (0.1) | .6518 |
| Thyroid | 7 | 1 (0.1) | 2 (0.1) | 4 (0.1) | .8799 |
| Leukemia | 1 | 0 (0.0) | 1 (0.1) | 0 (0.0) | .2556 |